{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:28:49Z","timestamp":1760297329509},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00108-004-1329-x","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T11:10:21Z","timestamp":1105441821000},"page":"48-56","source":"Crossref","is-referenced-by-count":2,"title":["H\u00e4mostasest\u00f6rungen bei onkologischen Patienten"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"von Depka Prondzinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000046583","volume":"106","author":"Rickles","year":"2001","unstructured":"Rickles FR, Levine MN (2001) Epidemiology of thrombosis in cancer. Acta Haematol 106: 6?12","journal-title":"Acta Haematol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0038-1651580","volume":"69","author":"Edwards","year":"1993","unstructured":"Edwards RL, Silver J, Rickles FR (1993) Human tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 69: 205?213","journal-title":"Thromb Haemost"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-0038-1647145","volume":"64","author":"Donati","year":"1990","unstructured":"Donati MB, Falanga A, Consonni R et al. (1990) Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemost 64: 11?16","journal-title":"Thromb Haemost"},{"key":"CR4","doi-asserted-by":"crossref","unstructured":"Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78: 285?291","DOI":"10.1097\/00005792-199909000-00001"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1378\/chest.124.3_suppl.58S","volume":"124","author":"Rickles","year":"2003","unstructured":"Rickles FR, Patierno S, Fernandez PM (2003) Tissue factor, thrombin, and cancer. Chest 124 [Suppl]: 58S?68S","journal-title":"Chest"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2003-40966","volume":"29","author":"Kwaan","year":"2003","unstructured":"Kwaan HC, Parmar S, Wang J (2003) Pathogenesis of increased risk of thrombosis in cancer. Semin Thromb Hemost 29: 283?290","journal-title":"Semin Thromb Hemost"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-994920","volume":"25","author":"Carroll","year":"1999","unstructured":"Carroll VA, Binder BR (1999) The role of the plasminogen activation system in cancer. Semin Thromb Hemost 25: 183?197","journal-title":"Semin Thromb Hemost"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0003319701052001S01","volume":"20","author":"Nicolaides","year":"2001","unstructured":"Nicolaides AN, Breddin HK, Fareed J et al.; Cardiovascular Disease Educational and Research Trust and the International Union of Angiology (2001) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20: 1?37","journal-title":"Int Angiol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","volume":"88","author":"Mismetti","year":"2001","unstructured":"Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88: 913?930","journal-title":"Br J Surg"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","volume":"346","author":"Bergqvist","year":"2002","unstructured":"Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F; ENOXACAN II Investigators (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346: 975?980","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","volume":"112","author":"Bern","year":"1990","unstructured":"Bern MM, Lokich JJ, Wallach SR et al. (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112: 423?428","journal-title":"Ann Intern Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","volume":"75","author":"Monreal","year":"1996","unstructured":"Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices?prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75: 251?253","journal-title":"Thromb Haemost"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2125.1998.00733.x","volume":"45","author":"Meier","year":"1998","unstructured":"Meier CR, Jick H (1998) Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 45: 608?612","journal-title":"Br J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00063198-200007000-00009","volume":"6","author":"Ornstein","year":"2000","unstructured":"Ornstein DL, Zacharski LR (2000) Cancer, thrombosis, and anticoagulants. Curr Opin Pulm Med 6: 301?308","journal-title":"Curr Opin Pulm Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A et al. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100: 3484?3488","journal-title":"Blood"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1046\/j.1538-7836.2003.00275.x","volume":"1","author":"Levine","year":"2003","unstructured":"Levine MN, Lee AY, Kakkar AK (2003) From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. J Thromb Haemost 1: 1456?1463","journal-title":"J Thromb Haemost"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","volume":"162","author":"Meyer","year":"2002","unstructured":"Meyer G, Marjanovic Z, Valcke J et al. (2002) Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. Arch Intern Med 162: 1729?1735","journal-title":"Arch Intern Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","volume":"82","author":"Hettiarachchi","year":"1999","unstructured":"Hettiarachchi RJ, Smorenburg SM, Ginsberg J, Levine M, Prins MH, Buller HR (1999) Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. Thromb Haemost 82: 947?952","journal-title":"Thromb Haemost"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-2000-13202","volume":"26","author":"Gross","year":"2000","unstructured":"Gross PL, Aird WC (2000) The endothelium and thrombosis. Semin Thromb Hemost 26: 463?478","journal-title":"Semin Thromb Hemost"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00003246-200009001-00011","volume":"28","author":"Fisher","year":"2000","unstructured":"Fisher CJ, Yan SB (2000) Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28 [Suppl]: S49?56","journal-title":"Crit Care Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)62333-1","volume":"77","author":"Kumar","year":"2002","unstructured":"Kumar S, Pruthi RK, Nichols WL (2002) Acquired von Willebrand disease. Mayo Clin Proc 77: 181?187","journal-title":"Mayo Clin Proc"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","volume":"351","author":"Mannucci","year":"2004","unstructured":"Mannucci PM (2004) Treatment of von Willebrand?s disease. N Engl J Med 351: 683?694","journal-title":"N Engl J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","volume":"18","author":"Slichter","year":"2004","unstructured":"Slichter SJ (2004) Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 18: 153?167","journal-title":"Transfus Med Rev"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","volume":"266","author":"Gaydos","year":"1962","unstructured":"Gaydos LA, Freireich EJ, Mantel N (1962) The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 266: 905?909","journal-title":"N Engl J Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","volume":"16","author":"Friedmann","year":"2002","unstructured":"Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S (2002) Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 16: 34?45","journal-title":"Transfus Med Rev"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1097\/01.CCM.0000100124.50579.D9","volume":"31","author":"Goodnough","year":"2003","unstructured":"Goodnough LT (2003) Risks of blood transfusion. Crit Care Med 31 [Suppl]: S678?686","journal-title":"Crit Care Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"Taylor","year":"2001","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M (2001) Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis ISTH Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327?1330","journal-title":"Thromb Haemost"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1329-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-004-1329-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-004-1329-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T08:22:57Z","timestamp":1586074977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-004-1329-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1007\/s00108-004-1329-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}